Apotex Inc. recalls Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged a…
- Recall date
- March 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0992-2019
- FDA classification
- Class II
- Brand / firm
- Apotex Inc.
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.03 mg, 28 Tablets Blister, 1 Unit (NDC 60505-4183-1) packaged as 84 Tablets Blister, 3x1 Unit per carton (NDC 60505-4183-3), Rx Only, Manufactured for: Apotex Corp., Weston, FL 33326; Manufactured by: Oman Pharmaceutical Products Co. L.L.C., P.O. Box 1885, Postal Code 111, Seeb.
Get recall alerts
Free email alert whenever Apotex Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Apotex Inc.